A unique product development partnership seeks to address the need for new therapeutics for Chagas disease by developing and testing vaccine candidate antigens that would eventually comprise a ...

The studies described above provide a strong preclinical foundation for accelerating the development of a therapeutic human vaccine for Chagas disease. The authors are currently working to produce ...

Main Goal: The overall goal of the project is to advance the first therapeutic Chagas disease vaccine prototype through a First-in-Human Phase 1 clinical trial. SARS-CoV Vaccine Development Main Goal: ...

Trypanosomes are parasites that cause sleeping sickness, Chagas disease, and various animal diseases. Diagnosis and treatment remain complex and no effective vaccine has been developed.

The initiative will focus on vaccines and medicines for diseases ... says it has earmarked $100 million for new treatments for Chagas disease, leishmaniasis, dengue fever and cryptosporidiosis ...

We also have a new Chagas disease vaccine entering a Phase 1 trial, and we used that same approach to make two low-cost COVID-19 vaccines. The health economists we collaborate with said all our ...

As a deliverable, the advancement in development of an urgently needed new medical intervention, a therapeutic vaccine for Chagas disease, one of the most important neglected tropical diseases in ...

Trypanosomes are parasites that cause sleeping sickness, Chagas disease, and various animal diseases. Diagnosis and treatment remain complex and no effective vaccine has been developed. A better ...

but millions of people are still estimated to be infected with Chagas disease. Diagnosis and treatment remain complex, and no effective vaccine has been developed for these neglected tropical ...